Assyro AI
FDA Orange Book · active-ingredient family

Chlorothiazide; methyldopa

Chlorothiazide; methyldopa: 1 brand, 2 generics; first approved Nov 06, 1987; generic available.

Generic availableHas discontinued products
Generic status & protection

Generic available — 2 ANDA applications approved.

Brands (NDA)
1
Generics (ANDA)
2
Listed patents
0
Presentations
4
Originator applications

Brand (NDA) products

NDA 0160162 strengths
Approved strengths under this FDA application.
StrengthDosage formRouteStatusTE
150MG;250MGTABLETORALDiscontinued
250MG;250MGTABLETORALDiscontinued
Abbreviated applications

Generic (ANDA) products (2)

ANDA 0707831987
Approved strengths under this FDA application.
StrengthDosage formRouteStatusTE
150MG;250MGTABLETORALDiscontinued
ANDA 0706541987
Approved strengths under this FDA application.
StrengthDosage formRouteStatusTE
250MG;250MGTABLETORALDiscontinued
Orange Book patent file

Listed patents

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

FDA approval span

Approval history

First approval
Nov 06, 1987
39 yr 3 mo ago
Most recent approval
Nov 06, 1987
39 yr 3 mo ago

All 3 applications were approved in 1987.

Brand (NDA) 133%
Generic (ANDA) 267%

Chlorothiazide; methyldopa — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Built directly from the FDA Orange Book data file (products, patents, and exclusivity). TE codes, RLD/RS flags, patent expirations, and exclusivity dates match the official FDA record. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Related FDA reference tools

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.